Raje, N., Vescio, R., Montgomery, C. W., Badros, A., Munshi, N., Orlowski, R., Hadala, J. T., Warsi, G., Argonza-Aviles, E., Ericson, S. G., Anderson, K. C. Bone Marker- Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Mye oma: Results of the Z-MARK Study. Clinical Cancer Research 2016; 6: 1378-84